Does CARMUSTINE Cause Second primary malignancy? 141 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Second primary malignancy have been filed in association with CARMUSTINE (carmustine). This represents 4.2% of all adverse event reports for CARMUSTINE.
141
Reports of Second primary malignancy with CARMUSTINE
4.2%
of all CARMUSTINE reports
82
Deaths
52
Hospitalizations
How Dangerous Is Second primary malignancy From CARMUSTINE?
Of the 141 reports, 82 (58.2%) resulted in death, 52 (36.9%) required hospitalization, and 13 (9.2%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARMUSTINE. However, 141 reports have been filed with the FAERS database.
What Other Side Effects Does CARMUSTINE Cause?
Off label use (454)
Febrile neutropenia (297)
Myelodysplastic syndrome (295)
Disease progression (241)
Acute myeloid leukaemia (180)
Thrombocytopenia (174)
Pyrexia (152)
Drug ineffective (149)
Mucosal inflammation (148)
Infection (139)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which CARMUSTINE Alternatives Have Lower Second primary malignancy Risk?
CARMUSTINE vs CARTEOLOL
CARMUSTINE vs CARVEDILOL
CARMUSTINE vs CASIMERSEN
CARMUSTINE vs CASIRIVIMAB
CARMUSTINE vs CASIRIVIMAB\IMDEVIMAB